Delayed Immune Response to SARS-CoV-2 Explain Why More Men Die from COVID-19
By HospiMedica International staff writers Posted on 10 Sep 2020 |
Image: This scanning electron microscope image shows SARS-CoV-2 (round blue objects), the virus that causes COVID-19, emerging from the surface of cells cultured in the lab (Photo courtesy of NIAID)
A study by researchers from the University of Washington (Seattle, Wash., USA) suggests that varying immune responses to SARS-CoV-2 due to age and sex could explain why COVID-19 infections tend to be more severe among older adults and males.
The SARS-CoV-2 virus causes more severe COVID-19 infections and higher mortality among elderly and male patients as compared to women, indicating that weaker immune responses may be contributing to the underlying poor clinical outcomes for these two demographics. However, scientists have not yet been able to understand the mechanisms behind the increased death rate among these two patient populations caused by SARS-CoV-2.
The University of Washington researchers attempted to better understand the mechanisms behind the varied response of COVID-19 infected patients among different demographics by extracting and sequencing viral RNA from swabs collected from 430 COVID-19 positive cases and 54 negative controls. The researchers then went on to analyze their antiviral and immune responses across infection status, viral load, age and sex. They found that the immune cell responses were activated only three days after the start of infection, and also observed fluctuations in immune cell composition and function with viral loads, pointing to a dysfunctional antiviral response in males and the elderly. The findings of the study have significant implications for the development of immunomodulatory treatments for SARS-CoV-2
In their study published in the open access journal PLOS Biology, the authors wrote, "Collectively, our data demonstrate that host responses to SARS-CoV-2 are dependent on viral load and infection time with observed differences due to age and sex that may contribute to disease severity."
Related Links:
University of Washington
The SARS-CoV-2 virus causes more severe COVID-19 infections and higher mortality among elderly and male patients as compared to women, indicating that weaker immune responses may be contributing to the underlying poor clinical outcomes for these two demographics. However, scientists have not yet been able to understand the mechanisms behind the increased death rate among these two patient populations caused by SARS-CoV-2.
The University of Washington researchers attempted to better understand the mechanisms behind the varied response of COVID-19 infected patients among different demographics by extracting and sequencing viral RNA from swabs collected from 430 COVID-19 positive cases and 54 negative controls. The researchers then went on to analyze their antiviral and immune responses across infection status, viral load, age and sex. They found that the immune cell responses were activated only three days after the start of infection, and also observed fluctuations in immune cell composition and function with viral loads, pointing to a dysfunctional antiviral response in males and the elderly. The findings of the study have significant implications for the development of immunomodulatory treatments for SARS-CoV-2
In their study published in the open access journal PLOS Biology, the authors wrote, "Collectively, our data demonstrate that host responses to SARS-CoV-2 are dependent on viral load and infection time with observed differences due to age and sex that may contribute to disease severity."
Related Links:
University of Washington
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans